Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 30-34

  Mangan, Bozgana A ^a   Dunne, Margaret R ^a   O'Reilly, Vincent P ^a   Dunne, Pádraic J ^a   Exley, Mark A ^b   O'Shea, Donal ^c,d   Scotet, Emmanuel ^e   Hogan, Andrew E ^c,d   Doherty, Derek G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD1D ANTIGEN; CD56 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; MITOGENIC AGENT; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKG2D; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANTIGENS, CD1D; CELL LINE; DENDRITIC CELLS; HUMANS; IMMUNOPHENOTYPING; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84879614529     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300121     Document Type: Article

References (21)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336. (Pubitemid 46697911)
2. Berzins, S. P., M. J. Smyth, and A. G. Baxter. 2011. Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 11: 131-142.
3. Le Bourhis, L., L. Guerri, M. Dusseaux, E. Martin, C. Soudais, and O. Lantz. 2011. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol. 32: 212-218.
4. + T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat. Immunol. 12: 616-623.
5. Morita, C. T., C. Jin, G. Sarikonda, and H. Wang. 2007. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215: 59-76. (Pubitemid 46212230)
6. Spada, F. M., E. P. Grant, P. J. Peters, M. Sugita, A. Melián, D. S. Leslie, H. K. Lee, E. van Donselaar, D. A. Hanson, A. M. Krensky, et al. 2000. Self-recognition of CD1 by γ/δ T cells: implications for innate immunity. J. Exp. Med. 191: 937-948.
7. Russano, A. M., G. Bassotti, E. Agea, O. Bistoni, A. Mazzocchi, A. Morelli, S. A. Porcelli, and F. Spinozzi. 2007. CD1-restricted recognition of exogenous and self-lipid antigens by duodenal γδ+T lymphocytes. J. Immunol. 178: 3620-3626. (Pubitemid 46417629)
8. Bai, L., D. Picard, B. Anderson, V. Chaudhary, A. Luoma, B. Jabri, E. J. Adams, P. B. Savage, and A. Bendelac. 2012. The majority of CD1d-sulfatide- specific T cells in human blood use a semiinvariant Vδ1 TCR. Eur. J. Immunol. 42: 2505-2510.
9. + natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol. Rev. 220: 183-198.
10. Galli, G., S. Nuti, S. Tavarini, L. Galli-Stampino, C. De Lalla, G. Casorati, P. Dellabona, and S. Abrignani. 2003. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197: 1051-1057. (Pubitemid 36523203)
11. Dunne, M. R., L. Madrigal-Estebas, L. M. Tobin, and D. G. Doherty. 2010. (E)-4-hydroxy-3-methyl-but-2 enyl pyrophosphate-stimulated Vγ9Vδ2 T cells possess T helper type 1-promoting adjuvant activity for human monocyte-derived dendritic cells. Cancer Immunol. Immunother. 59: 1109-1120.
12. Bansal, R. R., C. R. Mackay, B. Moser, and M. Eberl. 2012. IL-21 enhances the potential of human γδ T cells to provide B-cell help. Eur. J. Immunol. 42: 110-119.
13. Motohashi, S., Y. Okamoto, I. Yoshino, and T. Nakayama. 2011. Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer. Clin. Immunol. 140: 167-176.
14. Fournié, J. J., H. Sicard, M. Poupot, C. Bezombes, A. Blanc, F. Romagné, L. Ysebaert, and G. Laurent. 2013. What lessons can be learned from γδ T cell-based cancer immunotherapy trials? Cell. Mol. Immunol. 10: 35-41.
15. Déchanet, J., P. Merville, A. Lim, C. Retière, V. Pitard, X. Lafarge, S. Michelson, C. Méric, M. M. Hallet, P. Kourilsky, et al. 1999. Implication of γδ T cells in the human immune response to cytomegalovirus. J. Clin. Invest. 103: 1437-1449.
16. neg γδ T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J. Exp. Med. 201: 1567-1578.
17. Knight, A., A. J. Madrigal, S. Grace, J. Sivakumaran, P. Kottaridis, S. Mackinnon, P. J. Travers, and M. W. Lowdell. 2010. The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 116: 2164-2172.
18. Kabelitz, D., T. Hinz, T. Dobmeyer, U. Mentzel, S. Marx, A. Böhme, B. Arden, R. Rossol, and D. Hoelzer. 1997. Clonal expansion of Vγ3Vδ3-expressing γδ T cells in an HIV-1/2-negative patient with CD4 T-cell deficiency. Br. J. Haematol. 96: 266-271. (Pubitemid 27077358)
19. Bartkowiak, J., D. Kulczyck-Wojdala, J. Z. Blonski, and T. Robak. 2002. Molecular diversity of γδ T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia. Neoplasma 49: 86-90. (Pubitemid 34493666)
20. Kenna, T., L. Golden-Mason, S. Norris, J. E. Hegarty, C. O'Farrelly, and D. G. Doherty. 2004. Distinct subpopulations of γδ T cells are present in normal and tumor-bearing human liver. Clin. Immunol. 113: 56-63. (Pubitemid 39468268)
21. - invariant natural killer T cells. PLoS ONE 6: e28648.